- Biosimilar insulines - new possibilities of diabetes treatment2015 | First Faculty of Medicine
- miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?2015 | First Faculty of Medicine, Third Faculty of Medicine
- Long-acting insulins in the treatment of type 2 diabetes and their position in the current treatment algorithm2017 | First Faculty of Medicine
- Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications2021 | Faculty of Medicine in Hradec Králové
- What are biosimilars and what do they bring to us?2015 | Third Faculty of Medicine